Chairman of the Pharmaceutical Authority at the People of Egypt Hospital for burns
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, visited a special visit to the People of Egypt Hospital for the Treatment of Burns, affiliated to the People of Egypt Development Foundation, which is the first hospital in the Middle East and Africa specialized in treating the victims of burns for free The applicant provided by the hospital, and to know the integrated programs offered to the survivors of burns, which include medical, psychological and social care and professional rehabilitation, which contributes to enabling them to return to their lives naturally and effectively. In the areas of health care within the Arab Republic of Egypt, it also reflects the authority’s keenness to support national initiatives that contribute to improving the quality of citizens ’life, and enhancing ways of integration between the health sector and civil society, in a way that contributes to achieving the sustainable development goals in Egypt. Burn cases, through continuous follow -up mechanisms and coordination with production and distribution companies, to ensure the provision of these drugs with high quality, and to meet any urgent treatment needs for specialized hospitals and medical centers. The great civil society, which contributed greatly to providing health care to a wide sector of Egyptian society in all therapeutic and humanitarian fields. The Authority for Policies and International Cooperation and the supervisor of the Central Administration for Pharmaceutical Policies and Markets Support, Dr. Heba Allah Ibrahim, Director General of the General Administration of Biomedics in the Central Administration of Biomedics, and on the part of the People of Egypt Hospital, Dr. Refaat Abdel -Maksoud, CEO of the People of Egypt Hospital, Dr. Iman Sharif, CEO of the People of Egypt Foundation, Dr. Ahmed Rizk, President of the Medical Sector.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
